4DMedical (ASX:4DX) share price launches 19% on first commercial scans

The company’s shares are off to a flying start on Tuesday.
The post 4DMedical (ASX:4DX) share price launches 19% on first commercial scans appeared first on The Motley Fool Australia. –

The 4DMedical Ltd (ASX: 4DX) share price is shooting higher today following the rollout of the company’s respiratory imaging platform.

At the time of writing, 4DMedical shares are swapping hands for $1.43, up 19.17%.

4DMedical makes strides on XV LVAS

In today’s statement, 4DMedical advised it has partnered with I-MED Radiology Network (I-MED) for the commercial rollout of its XV Lung Ventilation Analysis Software (XV LVAS).

I-MED is Australia’s largest diagnostic imaging provider with more than 250 clinics across the country.

The first XV LVAS deployment will occur next month at the Berwick clinic in Melbourne after a successful pilot program. Clinicians and specialists based in and around the Casey region of Victoria, Australia, will soon be able to refer patients to I-MED’s state-of-the-art Berwick imaging clinic.

4DMedical’s proprietary XV LVAS technology converts X-ray images into a four-dimensional data package using mathematical models and algorithms. The platform then provides physicians with information about a patient’s lung motion and airflow. This enables the detection and monitoring of various lung diseases which can be managed or treated if possible.

The XV LVAS is expected to be further installed within hospitals and imaging centres, offering greater accessibility for all patients. This includes sites in Brisbane and Wagga Wagga in early 2022 and at selected locations across I-MED’s network thereafter.

In addition, all facilities with XV LVAS will be able to offer 4DMedical’s lung report for both inpatient and outpatient care. This in turn is expected to maximise the number of addressable patients for the company, effectively increasing revenue streams.

4DMedical is making progress with its commercial pilots in the United States. The company currently has a near-term commercialisation pipeline, particularly within the large and important Veterans Health Administration (VHA) healthcare system.

The respiratory diagnosis industry is worth an estimated US$31 billion per annum worldwide. The United States, the world’s largest healthcare market, represents an annual opportunity of US$13.7 billion.

About the 4DMedical share price

Despite today’s gain, 4DMedical shares have disappointed investors, with the company’s share price losing 40% over the last 12 months. The company’s share price hit a 6-month low of $1.16 yesterday before rebounding higher.

4DMedical has a market capitalisation of roughly $292 million, with more than 208.95 million shares outstanding.

The post 4DMedical (ASX:4DX) share price launches 19% on first commercial scans appeared first on The Motley Fool Australia.

Should you invest $1,000 in 4DMedical right now?

Before you consider 4DMedical, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why is the Pinnacle (ASX:PNI) share price frozen today?

Here’s why the Sovereign Cloud (ASX:SOV) share price is in the spotlight this week

Life360 (ASX:360) share price halted amid $280 million acquisition

Why ASIC chair warns ‘great caution’ needed when investing in crypto

Does the lower Zip Co (ASX:Z1P) share price make it a takeover target?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!